Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech OnKure Therapeutics Inc OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline MGNI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Sentiment CPSH Q1 2026 Earnings Significant EPS Miss Amidst Stock Surge Unclear Revenue Picture BBCP Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Confidence BSBR Q1 2023 Earnings Significant EPS Miss Sends Stock Lower